泌尿器科学論⽂
A

欧⽂

A-a
1 . Matsuo T,Miyata M,Otsubo A,Mukae Y, Mitsunari K,Ohba K,Sakai H: Efficacy of salt reduction for managing overactive
bladder symptoms: a prospective study in patients with excessive daily salt intake. SCIENTIFIC REPORTS 11(1):4046,2021. doi: 10.1038/s41598-021-83725-9. (IF: 4.996) ＊2 . Otsubo A,Miyata Y,Matsuo M,Mukae Y, Mitsunari K,Ohba K,Sakai H: Excessive accumulation of visceral fat is associatedwith lower urinary symptoms including overactive bladder in female patients.. International journal of urology 28(4): 397403,2021. doi: 10.1111/iju.14476. (IF: 2.869) ＊3 . Tamura K,Osawa T,Takeuchi A,Minami K,Nakai Y,Ueda K,Ozawa M,Uemura M,Sugimoto M,Ohba K,Suzuki T,Anai S,ShindoT,Kusakabe N,Komiyama M,Tanaka K,Yokomizo A,Kohei N,Shinohara N,Miyake H: External validation of the albumin, Creactive protein and lactate dehydrogenase model in patients with metastatic renal cell carcinoma receiving second-line
axitinib therapy in a Japanese multi-center cohort.. Japanese journal of clinical oncology 51(5): 810-818,2021. doi:
10.1093/jjco/hyaa264. (IF: 2.952) ＊4 . Harada J,Kihara T,Ogata T,Kinoshita F, Yamane Y,Sakai H: Spontaneous intraperitoneal renal rupture with urinoma formationin the fetus.. Urology case reports 37: 101697,2021. doi: 10.1016/j.eucr.2021.101697.
5 . Yamaguchi K,Kitamura M,Kawaguchi Y, Hayashi K,Muta K,Nakazawa M,Matsuda T,Onita T,Nishikido M,Sakai H,MukaeH,Nishino T: A case of early recurrent immunoglobulin A nephropathy and T-cell-mediated rejection in a transplant patientwith Wiskott-Aldrich syndrome.. CEN case reports : 2021. doi: 10.1007/s13730-021-00631-9. (IF: -)6 . Matsuo T, Nakamura T, Sato K, Miyata Y, Sakai H: Intravesical injection of onabotulinumtoxinA in neurogenic overactive
bladder patients with human T-cell leukemia virus type 1-associated myelopathy: A single-institution case series. IJU casereports. 4(4): 251-254,2021. doi: 10.1002/iju5.12301.
7 . Harada J,Miyata Y,Araki K,Matsuda T, Nagashima Y,Mukae Y,Mistunari K,Matsuo T,Ohba K,Mochizuki Y,Sakai H:
Pathological Significance and Prognostic Roles of Thrombospondin-3, 4 and 5 in Bladder Cancer. In Vivo 35(3): 16931701,2021. doi: 10.21873/invivo.12429. (IF: 2.155) ＊8 . Nakai Y,Takeuchi A,Osawa T,Kojima T,Hara T,Sugimoto M,Eto M,Minami K,Ueda K,Ozawa M,Uemura M,Miyauchi Y,OhbaK,Kashiwagi A, Murakami M,Sazuka T,Yasumoto H,Morizane S,Kawasaki Y,Morooka D,Shimazui T, Yamamoto Y,NakagomiH,Tomida R,Yoichi M Ito,Murai S,Kitamura H,Nishiyama H,Shinohara N: Efficacy and safety of second-line axitinib in
octogenarians with metastatic renal cell carcinoma.. Journal of geriatric oncology 12(5): 834-837,2021. doi:
10.1016/j.jgo.2020.12.012. (IF: 3.929) ＊9 . Ohba K, Miyata Y, Mukae Y, Mitsunari K, Matsuo T, Sakai H: Efficacy of propiverine hydrochloride for urinary incontinence
after robot-assisted or laparoscopic radical prostatectomy.. The Canadian journal of urology 28(3): 10706-10712,2021. (IF:1.344) ＊10 . Otsubo A,Matsuo T,Miyata Y,Mukae Y, Mitsunari K,Ohba K,Sakai H: Presurgical bladder wall thickness is a useful marker topredict the postsurgical improvement of symptoms in patients with pelvic organ prolapse-related overactive bladder. LUTS
13(3): 347-355,2021. doi: 10.1111/luts.12374. (IF: 1.374) ＊11 . Hrada J,Miyta Y,Tamai ,Matsuda T,Mukae Y,Mitsunari K,Matsuo T,Ohba K,Suda T,Sakai H,Ito A,Saito S: Stage-specific
Embryogenic Antigen-4 Expression in Castration-resistant Prostate Cancer and its Correlation With the Androgen Receptor.
Anticancer Research 41(7): 3327-3335,2021. doi: 10.21873/anticanres.15120. (IF: 2.435) 〇＊12 . Aibara N,Miyata Y,Araki K,Sagara Y,Mitsunari M,Matsuo T,Ohba K,Mochizuki Y,Sakai H,Ohyama K: Detection of novel
urine markers using immune complexome analysis in bladder cancer patients: A preliminary study. In Vivo 35(4): 20732080,2021. doi: 10.21873/INVIVO.12476. (IF: 2.155) ＊13 . Otsubo A,Miyazato M,Oshiro T,Kimura R,Matsuo T,Miyata Y,Sakai H: Age-associated bladder and urethral coordination
impairment and changes in urethral oxidative stress in rats. Life Sciences 279: 119690,2021. doi:
10.1016/j.lfs.2021.119690. (IF: 5.037) ＊14 . Mukae Y,Ito H,Miyata Y,Araki K, Matsuda T,Aibara N,Nakamura Y,Matsuo T,Sakai H,Ohyama K: Ceruloplasmin Levels inCancer Tissues and Urine Are Significant Biomarkers of Pathological Features and Outcome in Bladder Cancer.. Anticancer
research 41(8): 3815-3823,2021. doi: 10.21873/anticanres.15174. (IF: 2.435) ＊15 . Miyata Y,Tsurusaki T,Hayashida Y, Imasato Y,Takehara T,Aoki D, Nishikido M, Watanabe J,Mitsunari K,Matsuo T,Ohba K,Taniguchi T,Sakai H: Intravesical mitomycin C (MMC) and MMC + cytosine arabinoside for non-muscle-invasive bladdercancer: a randomised clinical trial.. BJU international : 2021. doi: 10.1111/bju.15571. (IF: 5.969) ＊1

16 . Harada J,Shida Y,Gono S,Masato M,Yuno T,Hakariya T,Kihara T,Maeda K,Miyata Y,Sakai H: Rare case of penile fracturecaused by an injury to the crus penis: Delayed repair using the transperineal approach.. IJU case reports 4(1): 36-38,2021.
doi: 10.1002/iju5.12232.
17 . Miyata Y,Masato M,Mukae Y, Nakamura Y,Matsuda T,Harada J,Mitsunari K, Matsuo T,Ohba K,Sakai H: Pathological Roles of
Prostaglandin E2-specific E-type Prostanoid Receptors in Hormone-sensitive and Castration-resistant Prostate Cancer..
Anticancer research 41(9): 4333-4341,2021. doi: 10.21873/anticanres.15238. (IF: 2.435) ＊18 . Sadahira T,Maruyama Y,Hiyama Y,Kitano H,Yamada H,Goto T,Kondo T,Shigemura K,Mitsui Y,Iwata T,Edamura K,ArakiM,Watanabe M,Takenaka T,Teishima J,Miyata Y,Ishikawa K,Takaoka E,Miyazaki J,Takahashi S,Masumori N,Kiyota H,MFujisawa M,Yamamoto S,Sakuma T,Kusumi N,Ichikawa T,Watanabe T,Nasu Y,Tsugawa M,Nasu Y,Wada K: A Clinical Trial
Evaluating the Usefulness of Tailored Antimicrobial Prophylaxis Using Rectal-culture Screening Media Prior to Transrectal
Prostate Biopsy: A Multicenter, Randomized Controlled Trial.. Acta medica Okayama 75(5): 663-667,2021. doi:
10.18926/AMO/62782. (IF: 0.892)
19 . Tobu T,Udo K,Nishihara K,Miyajima S, Ando T,Onizuka C,Itesako T,Ashikari A,Hakariya T,Igawa T,Tanaka M,Shin T,KamotoT, Nakagawa M,Saito S,Sakai H,Eto M, Kamba T, Fujimoto N,Noguchi M: Surveillance of urachal abscess in the KyushuOkinawa area of Japan.. International journal of urology 28(10): 1008-1011,2021. doi: 10.1111/iju.14637. (IF: 2.869) ＊20 . Kanno T,Yamasaki T,Komai Y,Ohba K,Miki J: Management of venous bleeding during laparoscopic renal surgery:
Experiences in the usefulness of soft coagulation and TachoSil.. International journal of urology 28(9): 976-977,2021. doi:
10.1111/iju.14598. (IF: 2.869) ＊21 . Masato M,Miyata Y,Kurata H,Ito H,Mitsunari K,Asai A,Nakamura Y,Araki K,Mukae Y,Matsuda T,Harada J,Matsuo T,Ohba K,
Sakai H: Oral administration of E-type prostanoid (EP) 1 receptor antagonist suppresses carcinogenesis and development ofprostate cancer via upregulation of apoptosis in an animal model.. Scientific reports 11(1): 20279,2021. doi:
10.1038/s41598-021-99694-y. (IF: 4.996) ＊22 . Matsuda T,Miyata Y,Nakamura Y,Otsubo A, Mukae Y,Harada J,Mitsunari K,Matsuo T, Ohba K,Furusato B,Sakai H:
Pathological significance and prognostic role of LATS2 in prostate cancer.. The Prostate 81(15): 1252-1260,2021. doi:
10.1002/pros.24226. (IF: 4.012) 〇＊23 . Miyata Y,Matsuo T,Nakamura Y,Mitsunari K,Ohba K,Sakai H: Pathological Significance of Macrophages in Erectile
Dysfunction Including Peyronie's Disease.. Biomedicines 9(11): 1658,2021. doi: 10.3390/biomedicines9111658. (IF:4.757) ＊24 . Ohba K,Miyata Y,Shinzato T,Funakoshi S,Maeda K,Matsuo T,Mitsunari K,Mochizuki Y,Nishino T,Sakai H: Effect of oralintake of royal jelly on endothelium function in hemodialysis patients: study protocol for multicenter, double-blind,randomized control trial.. Trials 22(1): 950,2021. doi: 10.1186/s13063-021-05926-x. (IF: 2.728) ＊A-b
1 . Mitsunari K,Miyata Y,Matsuo T,Mukae Y,Otsubo A,Harada J,Kondo T,Matsuda T,Ohba K,Sakai H: Pharmacological Effects
and Potential Clinical Usefulness of Polyphenols in Benign Prostatic Hyperplasia. MOLECULES 26(2): 450,2021. doi:
10.3390/molecules26020450. (IF: 4.927) ＊A-e-2
1 . Matsuo T,Miyata Y,Sakai H: Editorial Comment to Does cognitive behavioral therapy using a self-check sheet improvenight-time frequency in patients with nocturia? Results of a multicenter randomized controlled trial.. International journalof urology 28(4): 449,2021. doi: 10.1111/iju.14516. (IF: 2.869) ＊2 . Ohba K: Editorial Comment to Spontaneous regression of multiple pulmonary metastases accompanied by normalization ofserum immune markers following cytoreductive nephrectomy in a patient with clear-cell renal cell carcinoma.. IJU casereports 4(2): 100,2021. doi: 10.1002/iju5.12256.
3 . Matsuo T, Miyata Y,Sakai H: Editorial Comment to Does cognitive behavioral therapy using a self-check sheet improvenight-time frequency in patients with nocturia? Results of a multicenter randomized controlled trial. Int J Urol 28(4):449,2021. doi: 10.1111/iju.14516. (IF: 2.896) ＊4 . Mitsunari K: Editorial Comment from Dr Mitsunari to Intraprostatic prophylactic antibiotic injection in patients
undergoing transrectal ultrasonography-guided prostate biopsy.. International journal of urology 28(6): 687,2021. doi:
10.1111/iju.14555. (IF: 2.869) ＊5 . Miyata Y,Matsuo M,Sakai H: Editorial Comment to Green-light laser en bloc resection versus conventional transurethralresection for initial non-muscle-invasive bladder cancer: A randomized controlled trial. International journal of urology :2021. doi: 10.1111/iju.14607. (IF: 2.869) ＊2

B邦⽂

B-a
1 . 松岡 弘文,坪内 和女,田中 正利,羽賀 宣博,山口 孝則,鯉川 弥須宏,宮里 実,斎藤 誠一,木原 敏晴,宮田 康好,望月 保志,酒井 英樹,榎田 英樹,速見 浩士,中川 昌之,森 健一,秦 聡孝,上村 敏雄,向井 尚一郎,賀本 敏行,猪口 淳一,江藤 正俊,藤本 直浩,末金 茂
高,松尾 光哲,井川 掌,東武 昇平,野口 満,西 一彦,神波 大己,石井 龍：逆流性腎症の術後長期予後に関わる要因の検討 第18回九州泌尿器科連合地方会共同研究. 西日本泌尿器科 82(6): 570-578, 2021.
2 . 松田 剛,望月保志,河田 賢,郷野すずな,迎 祐太,中西裕美,光成健輔,松尾朋博,大庭康司郎,宮田康好,酒井英樹,山 鮎子,北村峰昭,西野友哉：尿路感染症を契機に敗血症性ショックからARDSを発症した高齢生体腎移植レシピエントの1例. 西日本泌尿器科 82(6): 601-604, 2021.
3 . 光成 健輔,大庭 康司郎,松尾 朋博,志田 洋平,計屋 知彰,宮田 康好,酒井 英樹：腹腔鏡下前立腺全摘術とロボット支援腹腔鏡下前立腺全摘術の比較. Japanese Journal of Endourology 34(1): 136-142, 2021.
4 . 計屋知彰：長崎市

前立腺がん検診の現況. 日本腎泌尿器疾患予防医学研究会誌 29(1): 47-49, 2021.

5 . 原田 淳樹,木原 敏晴,山根 裕介,上紙 航,杠葉 美樹,宮田 康好,酒井 英樹：閉鎖腟の自然穿破により幼児期に閉鎖腟壁中隔開窓術および腎摘除術を施行したOHVIRA症候群の1例. 日本小児泌尿器科学会雑誌 30(1): 71-77, 2021.
6 . 中嶋有美子,白川利彦,野中双葉,草野千佳子,宮崎あかね,本川未都里,渡辺麻美,原口康平,里龍晴,小形勉,伊達木澄人,森内浩
幸,木原敏晴,中山裕介：急性巣状細菌性腎炎の２小児例. 長崎医学会雑誌 96(1): 1-10, 2021.
7 . 松田 剛,望月 保志,郷野 すずな,迎 祐太,中西 裕美,光成 健輔,松尾 朋博,大庭 康司郎,山下 鮎子,北村 峰昭,宮田 康好,西野 友哉,酒井 英樹：無症状の肺クリプトコッカス症からクリプトコッカス髄膜炎を発症した生体腎移植の1例. 日本臨床腎移植学会雑誌 9(1): 100-104, 2021.
8 . 原田淳樹,木原敏晴,河田賢,郷野すずな,左川 遼,近藤 翼,湯野 努,志田洋平,計屋知彰,小阪太一郎,伊達木澄人,宮田康好,酒井英樹：片側腎無形成が強く疑われた先天性片側精管欠損症の1例. 日本泌尿器科学会雑誌 112(3): 154-158, 2021.

9 . 坂井正裕,橋口麻夕子,中鋪 卓,大仁田賢,中村 勇,大庭康司郎：
超音波内視鏡下穿刺吸引法にて腎癌膵転移と診断された腹膜透析の1例. 腎と透析 91(別冊): 166-168, 2021.
10 . 伊藤秀德,松尾朋博,光成健輔,大庭康司郎,宮田康好,酒井英樹：下部尿路症状を有する患者における泌尿器科初診時の口内乾燥の実態. 臨床と研究 98(10): 1235-1240, 2021.
B-b
1 . 松尾朋博,宮田康好,酒井英樹：【朝まで待てない!夜間頻尿完全マスター】夜間頻尿の治療 夜間多尿に対する生活指導・行動療法. 臨床泌尿器科 75(1): 52-56, 2021.
2 . 木原 敏晴：JOURNAL IN JOURNAL-Focus On Your Direction-泌尿器科 専門領域の最新情報(vol.7)先天疾患 停留精巣.
Uro-Lo: 泌尿器Care & Cure 26(2): 296-302, 2021.
3 . 大庭康司郎,宮田康好,酒井英樹：転移性腎がんに対する薬物治療の展望. 泌尿器科 14(1): 123-130, 2021.
4 . 酒井英樹：【腎疾患治療薬update】(第3章)泌尿器科疾患排尿障害(前立腺肥大症)

5α還元酵素阻害薬. 腎と透析

91(増刊): 644-647, 2021.
5 . 計屋知彰：去勢抵抗性前立腺癌 game changers mCRPC治療におけるRa-223の出番は?
使用ポイント. 西日本泌尿器科 83(3): 127-131, 2021.
6 . 大庭康司郎,宮田康好,酒井英樹：転移性腎癌の治療
32, 2021.

Combinationを含めた今後のICI時代における当科のmRCC治療戦略. 西日本泌尿器科 84(1): 28-7 . 酒井英樹：【後期研修医がおさえておきたい泌尿器疾患TOP30 2021】エッセンシャルアイテム
科 34(特別号): 87-91, 2021.

3内分泌検査. 泌尿器外論文研究業績集計表
論文数一覧
2021

A-aA-bA-cA-dA-e

合計

SCI

B-aB-bB-cB-dB-e

合計

総計

24100530

24

10800018

48

学会発表数一覧
A-a2021

A-bｼﾝﾎﾟｼﾞｳﾑ

A-b
学会

合計

B-aB-b
ｼﾝﾎﾟｼﾞｳﾑ

B-b学会

合計

総計

077023941480

論文総数に係る教員生産係数一覧

2021

欧文論文総数教員生産係数

SCI 掲載論文数

教員生産係数論文総数（欧文論文）

欧文論文総数（SCI 掲載論文）

0.625

3.333

0.800

2.667

Impact Factor値一覧
2021

Impact Factor

教員当たりのImpact Factor

論文当たりのImpact Factor

79.6388.849

3.3184